Polonio Alcalá, E., Palomeras Pairet, S., Torres Oteros, D., Relat, J., Planas i Grabuleda, M., Feliu Soley, L., . . . Puig i Miquel, T. (2020). Fatty Acid Synthase Inhibitor G28 Shows Anticancer Activity in EGFR Tyrosine Kinase Inhibitor Resistant Lung Adenocarcinoma Models.
Citación estilo ChicagoPolonio Alcalá, Emma, Sònia Palomeras Pairet, Daniel Torres Oteros, Joana Relat, Marta Planas i Grabuleda, Lidia Feliu Soley, Quim de Ciurana, Santiago Ruiz Martínez, y Teresa Puig i Miquel. Fatty Acid Synthase Inhibitor G28 Shows Anticancer Activity in EGFR Tyrosine Kinase Inhibitor Resistant Lung Adenocarcinoma Models. 2020.
Cita MLAPolonio Alcalá, Emma, et al. Fatty Acid Synthase Inhibitor G28 Shows Anticancer Activity in EGFR Tyrosine Kinase Inhibitor Resistant Lung Adenocarcinoma Models. 2020.